LTP12 study materials
LTP12 study resources

The Delta Check That Fires on a Transplant Patient

LTP12 ยท Put your knowledge to work in context.

All case studies

The Delta Check That Fires on a Transplant Patient

A 47-year-old kidney transplant recipient has been monitored at the same hospital for 3 years. Their creatinine has been stable at 1.3โ€“1.5 mg/dL. On a routine visit, the result is 2.4 mg/dL - a 71% increase from the previous value of 1.4 mg/dL drawn 6 days earlier. The laboratory's delta check rule for creatinine flags a change greater than 0.3 mg/dL or 30%, whichever is smaller. The result is flagged and held for review. The specimen was collected at 07:45 in an outpatient draw station, transported on ice, centrifuged at 10:30, and analyzed at 11:15. The patient's tacrolimus level drawn the same day is 8.2 ng/mL (therapeutic range 5โ€“12). The previous specimen was collected at the same draw station at 09:20 and processed within 90 minutes.

1. Is the delta check flag most likely a true change or a preanalytical artifact? Build the argument from the specific details.

Read the worked answer

The flag is a genuine signal that must be taken seriously, but the preanalytical details raise a specific artifact concern that must be excluded first.

Arguments for a true change:

  • A 71% rise in creatinine in 6 days in a transplant patient is clinically plausible - acute rejection, calcineurin-inhibitor toxicity, dehydration, or obstruction can do this. Tacrolimus at 8.2 ng/mL is therapeutic, which does not exclude toxicity but makes it less likely.
  • The delta check is doing exactly what it is designed to do: catching a clinically important change.

Arguments for artifact - and they are specific:

  • Transport on ice. The current specimen was transported on ice; the previous one was not described as such. If the specimen was chilled and then allowed to warm, or if the cells were not separated promptly, cold-induced cell swelling and hemolysis can affect some analytes. For creatinine specifically, the more relevant issue is the delay to centrifugation: collection 07:45, centrifugation 10:30 - 2 hours 45 minutes. The previous specimen was processed within 90 minutes. A 2h45m delay is a documented preanalytical variable for several analytes, and the discrepancy in processing time between the two specimens is a confounder in the delta comparison.
  • The comparison is not apples-to-apples. A delta check compares two measurements; if the two specimens were handled differently, the delta reflects handling as well as biology.

The correct conclusion: the flag is not dismissible, but the preanalytical difference must be excluded - ideally by a repeat draw processed within the lab's standard window - before the result is treated as a true change.

2. What should the laboratory do before releasing the 2.4 mg/dL, and how should it communicate with the clinician?

Read the worked answer

Before release:

  1. Verify the specimen identity and integrity - check tube labeling, hemolysis index, and whether the tube was properly filled. A short draw in a serum tube can affect some analytes.
  2. Check the analyzer and QC - confirm glucose/creatinine QC was in control on the run and calibration current. Rule out an analytical cause before invoking preanalytical ones.
  3. Request a repeat specimen processed within the standard window if the clinician's timeline permits. A repeat drawn and processed like the previous specimen would make the comparison valid.
  4. If a repeat cannot be obtained promptly, release the result with an explicit comment: the value is flagged by delta check, the specimen had a prolonged time to centrifugation (2h45m) compared with the prior specimen (90 min), and the result should be interpreted with that in mind. Do not suppress the value - a 2.4 in a transplant patient is clinically important even if partly artifactual.

Communication: Call the clinician. State the value, the delta, the processing difference, and the recommendation for a repeat. Ask whether the patient has symptoms (decreased urine output, weight gain, fever) that would change the urgency. Document the call, the time, and the clinician's response. The goal is not to decide for the clinician whether this is rejection - it is to give them the value and the caveat together so they can act.